Finally, having provided support to the hypothesis that cerebellar dysfunction is associated with Hipk2 loss in Purkinje cells, this study raises the possibility that Hipk2 may be considered a potential therapeutic target for treating some forms of cerebellar ataxia. The gene discussed is HIPK2; the disease is aceruloplasminemia.